This paper is only available as a PDF. To read, Please Download here.
The topical agents developed thus far to treat male-pattern baldness have provided encouraging results, but with continued efforts other new, more effective compounds are certain to be developed in the future in this promising new area of dermatologic research.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Clinics in Dermatology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Topical minoxidil therapy for hereditary male pattern alopecia.Cutis. 1987; 39: 337-342
- Hypotensive agents: diazoxide. 24. American Society of Hospital Pharmacists, ]Bethesda1987: 809-812
- Hypertrichosis due to diazoxide.Br J dermatol. 1975; 93: 707-711
- A double blind, placebo controlled study assessing the efficacy of CL 115–347 in promoting hair growth when administered for 24 weeks to the scalp of male subjects with male pattern baldness.CL 115–347, Clinical Study Protocol. 1985; (data of file): 1-28
- Cyclosporine and male pattern alopecia.Arch dermatol. 1987; 123: 1432
© 1988 Published by Elsevier Inc.